Haverford Financial Services, Inc. Johnson & Johnson Transaction History

Haverford Financial Services, Inc.

  • $314 Million
  • Q4 2024

A detailed history of Haverford Financial Services, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Haverford Financial Services, Inc. holds 56,128 shares of JNJ stock, worth $8.76 Million. This represents 2.59% of its overall portfolio holdings.

Number of Shares
56,128
Previous 59,979 6.42%
Holding current value
$8.76 Million
Previous $9.72 Million 16.49%
% of portfolio
2.59%
Previous 2.79%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$143.34 - $165.86 $552,002 - $638,726
-3,851 Reduced 6.42%
56,128 $8.12 Million
Q3 2024

Oct 28, 2024
BUY
$145.48 - $167.38 $145 - $167
1 Added 0.0%
59,979 $9.72 Million
Q2 2024

Aug 12, 2024
SELL
$144.38 - $157.78 $65,837 - $71,947
-456 Reduced 0.75%
59,978 $8.77 Million
Q1 2024

Apr 30, 2024
SELL
$155.22 - $162.74 $67,831 - $71,117
-437 Reduced 0.72%
60,434 $9.56 Million
Q4 2023

Feb 08, 2024
BUY
$145.6 - $158.88 $34,507 - $37,654
237 Added 0.39%
60,871 $9.54 Million
Q3 2023

Nov 09, 2023
SELL
$155.75 - $174.48 $24,452 - $27,393
-157 Reduced 0.26%
60,634 $9.44 Million
Q2 2023

Aug 07, 2023
SELL
$154.35 - $166.11 $36,889 - $39,700
-239 Reduced 0.39%
60,791 $10.1 Million
Q1 2023

May 12, 2023
BUY
$151.05 - $180.26 $878,808 - $1.05 Million
5,818 Added 10.54%
61,030 $9.46 Million
Q4 2022

Feb 07, 2023
SELL
$160.2 - $179.79 $4,485 - $5,034
-28 Reduced 0.05%
55,212 $9.75 Million
Q3 2022

Nov 14, 2022
SELL
$161.33 - $179.52 $2,742 - $3,051
-17 Reduced 0.03%
55,240 $9.02 Million
Q2 2022

Aug 12, 2022
BUY
$168.19 - $186.01 $653,081 - $722,276
3,883 Added 7.56%
55,257 $9.81 Million
Q1 2022

May 02, 2022
SELL
$158.14 - $179.59 $117,339 - $133,255
-742 Reduced 1.42%
51,374 $9.11 Million
Q4 2021

Feb 10, 2022
SELL
$155.93 - $173.01 $331,507 - $367,819
-2,126 Reduced 3.92%
52,116 $8.92 Million
Q3 2021

Nov 12, 2021
SELL
$161.5 - $179.47 $9,367 - $10,409
-58 Reduced 0.11%
54,242 $8.76 Million
Q2 2021

Aug 16, 2021
SELL
$159.48 - $171.07 $7,655 - $8,211
-48 Reduced 0.09%
54,300 $8.95 Million
Q1 2021

May 11, 2021
SELL
$153.07 - $170.48 $60,156 - $66,998
-393 Reduced 0.72%
54,348 $8.93 Million
Q4 2020

Feb 04, 2021
SELL
$137.11 - $157.38 $9,186 - $10,544
-67 Reduced 0.12%
54,741 $8.62 Million
Q3 2020

Nov 10, 2020
BUY
$140.38 - $153.83 $98,827 - $108,296
704 Added 1.3%
54,808 $8.16 Million
Q2 2020

Aug 13, 2020
SELL
$128.81 - $155.51 $790,893 - $954,831
-6,140 Reduced 10.19%
54,104 $7.61 Million
Q1 2020

May 11, 2020
SELL
$111.14 - $153.99 $30,785 - $42,655
-277 Reduced 0.46%
60,244 $7.9 Million
Q4 2019

Feb 10, 2020
SELL
$127.5 - $146.44 $271,192 - $311,477
-2,127 Reduced 3.4%
60,521 $8.83 Million
Q3 2019

Nov 04, 2019
SELL
$126.95 - $142.14 $71,853 - $80,451
-566 Reduced 0.9%
62,648 $8.11 Million
Q2 2019

Aug 13, 2019
SELL
$131.15 - $144.24 $37,508 - $41,252
-286 Reduced 0.45%
63,214 $8.8 Million
Q1 2019

May 09, 2019
BUY
$125.72 - $139.79 $35,075 - $39,001
279 Added 0.44%
63,500 $8.88 Million
Q4 2018

Feb 12, 2019
SELL
$122.84 - $147.84 $97,657 - $117,532
-795 Reduced 1.24%
63,221 $8.16 Million
Q3 2018

Nov 08, 2018
SELL
$121.58 - $142.88 $64,680 - $76,012
-532 Reduced 0.82%
64,016 $8.85 Million
Q2 2018

Aug 10, 2018
SELL
$119.4 - $131.76 $134,683 - $148,625
-1,128 Reduced 1.72%
64,548 $7.83 Million
Q1 2018

May 09, 2018
SELL
$125.1 - $148.14 $126,225 - $149,473
-1,009 Reduced 1.51%
65,676 $8.42 Million
Q4 2017

Feb 13, 2018
SELL
$131.22 - $143.62 $17,321 - $18,957
-132 Reduced 0.2%
66,685 $9.32 Million
Q3 2017

Nov 09, 2017
SELL
$129.47 - $135.38 $2.42 Million - $2.53 Million
-18,662 Reduced 21.83%
66,817 $8.69 Million
Q2 2017

Aug 14, 2017
BUY
N/A
85,479
85,479 $11.3 Million

Others Institutions Holding JNJ

# of Institutions
4,473
Shares Held
1.73B
Call Options Held
16.7M
Put Options Held
14.6M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $408B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Haverford Financial Services, Inc. Portfolio

Follow Haverford Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Haverford Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email